Table 2 Patient characteristics at follow-up

Follow-up time, months, median (IQR )*

67 (28-108)

Died, n (%)

18 (15)

Start of kidney replacement therapy, n (%)

29 (24)

50 % decline of eGFR, n (%)

8 (7)

Systolic blood pressure (mmHg), mean (SD)

146 (23)

Diastolic blood pressure (mmHg), mean (SD)

90 (13)

Blood pressure < 140/ 90 mmHg, n (%) †

33 (36)

BP 140-160/90-100 mmHg, n (%)

42 (46)

BP 160-180/100-110 mmHg, n (%)

12 (13)

BP > 180/100 mmHg, n (%)

5 (5)

ACE-inhibitor or ARB, n (%)

74 (80)

Beta-blocking agent, n (%)

61 (66)

Calcium-antagonist, n (%)

79 (86)

Diuretic, n (%)

64 (70)

Alfa-blocking agent, n (%)

18 (20)